Vitamin A supplements are well tolerated with the pentavalent vaccine

Vaccine

Volumn 26, Issue 51, 2008, Pages 6608-6613

  Newton, Sam ^a   Owusu Agyei, Seth ^a,b   Filteau, Suzanne ^b   Gyan, Thomas ^a   Kirkwood, Betty R ^b  

^a Kintampo Health Research   (Ghana)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Haemophilus influenzae type b; Hepatitis B; Reactogenicity; Safety; Vitamin A

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; RETINOL; TRITANRIX HB PLUS HIBERIX; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COUGHING; CRYING; DIPHTHERIA; DRUG MEGADOSE; DRUG MIXTURE; DRUG SAFETY; FEMALE; FEVER; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INJECTION SITE PAIN; INJECTION SITE SWELLING; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TETANUS; TETANUS PROPHYLAXIS; VITAMIN SUPPLEMENTATION;

DIETARY SUPPLEMENTS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INFANT; VACCINES, CONJUGATE; VITAMIN A;

EID: 58149197791     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.037     Document Type: Article

References (36)

1. Beaton GH, Martorell R, Aronson KJ. Effectiveness of vitamin A supplementation in control of young child morbidity and mortality in developing countries. State of the Art Series Nutrition Policy Discussion Paper No 13. United Nations ACC/SCN; 1993
2. Ghana Vast Study Team. Vitamin A supplementation in Northern Ghana: effects on clinic attendances, hospital admissions and child mortality. Lancet 342 (1993) 7-12
3. Barreto M.L., Santos L.M., Assis A.M., Araujo M.P., Farenzena G.G., Santos P.A., et al. Effect of vitamin A Supplementation on diarrhoea and acute lower respiratory tract infections in young children in Brazil. Lancet 344 (1994) 228-231
4. Expanded Programme on Immunization Global Advisory Group. WHO Weekly Record 1987;65:5-12.
5. World Health Organization. The potential contribution of the Expanded Programme of Immunisation to the control of vitamin A and iodine deficiency disorders. A discussion document submitted to the EPI Global Advisory Group Meeting, EPI/ GAG/87/WP.17. Washington, DC, November 9-13 (1987), Geneva, World Health Organization
6. Rahman M.M., Mahalanabis D., Hossain S., Wahed M.A., Alvare J.O., Siber G.R., et al. Simultaneous Vitamin A administration at Routine Immunization Contacts enhances antibody responses to Diphtheria Vaccine in Infants Younger than six months. J Nutr 129 (1999) 2192-2195
7. Kutukculer N., Akil T., and Egemen Z. Adequate immune responses to tetanus toxoid and failure of vitamin A and E supplementation to enhance antibody response in healthy children. Vaccine 18 (2000) 2979-2984
8. Brown K.H., Rajan M.M., Chakraborty J., and Aziz K.M. Failure of a large dose of vitamin A to enhance the antibody response to tetanus toxoid in children. Am J Clin Nutr 33 2 (1980) 212-217
9. Kutty P.M., Mohanram M., and Vinodini R. Humoral immune response in vitamin A deficient children. Acta Vitaminol Enzymol 3 (1981) 231-235
10. Bhaskaram P., Jyothi K.V., Rao V., and Rao B.S.N. Effects of subclinical vitamin A deficiency and administration of vitamin A as a single large dose on immune function in children. Nutr Res 9 (1989) 1017-1025
11. Newton S.K., Owusu-Agyei S., Ampofo W., Zandoh C., Adjuik M., Tchum S., et al. Vitamin A supplementation enhances infants' immune responses to hepatitis B vaccine but does not affect responses to Haemophilus influenzae type b vaccine. J Nutr 137 May (5) (2007) 1272-1277
12. Newton S., Cousens S., Owusu-Agyei S., Filteau S., Stanley C., Linsell L., et al. Vitamin A supplementation does not affect infants' immune responses to polio and tetanus vaccines. J Nutr 135 (2005) 2669-2673
13. Sommer A., and Davidson F.R. Assessment and control of vitamin A deficiency: the Annecy Accords. J Nutr 132 (2002) 2845-2850
14. WHO/CHD Immunization Linked Vitamin A Supplementation Study Group. Randomized trial to assess benefits and safety of vitamin A linked to immunization in early infancy. Lancet 352 (1998) 1257-1263
15. Benn C.S., Fisker A.B., Jorgensen M.J., and Aaby P. Why worry: vitamin A with DTP vaccine?. Vaccine 25 (2007) 777-779
16. Mahalanabis D., Rahman M., Wahed M.A., Islam M.A., and Habte D. Vitamin A megadoses during early infancy on serum retinal concentration and acute side effects and residual effects on 6 month follow-up. Nutr Res 17 (1997) 649-659
17. De Francisco A., Chakraborty J., Chowdhury H.R., Yunus M., Baqui A.H., Siddique, et al. Acute toxicity of vitamin A given with vaccines in infancy. Lancet 342 (1993) 526-527
18. Filteau S.M., and Tomkins A.M. Vitamin A supplementation in developing countries. Arch Dis Child 72 (1995) 106-107
19. Baqui A.H., De Francisco A., Arifeen S.E., Siddique A.K., and Sack R.B. Bulging fontanelle after supplementation with 25,000 IU of vitamin A in infancy using immunisation contacts. Acta Paediatr 84 8 (1995) 863-866
20. Semba R.D. The role of vitamin A and related retinoids in immune function. Nutr Rev 56 (1998) S38-S48
21. Aristegui J., Dal-Re R., Garrote E., Gonzalez A., Arrate J.P., and Rerez A. Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2,4 and 6 months of age. Vaccine (1998) 1976-1981
22. Zepp F., Schuind A., Meyer C., Sanger R., Kaufhold A., and Willems P. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib and OPV vaccines in infants. Pediatrics 109 (2002) 1-8
23. Win K.M., Aye M., Htay Htay H., Safary A., and Bock H.L. Comparison of separate and mixed administration of DTPw-HBV and Hib vaccines: immunogenicity and reactogenicity profiles. Int J Infect Dis 2 (1997) 79-84
24. Kanra G., Silier T., Yurdakok K., Yavuz K., Baskan S., Ulukol S., et al. Immunogenicity trial of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus Influenzae type b vaccine (DTaP-IPV/PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life. Vaccine 18 (2000) 947-954
25. Dagan R., Botujansky C., Watemberg N., Arbelli Y., Belmaker I., Ethevenaux C., et al. Safety and immunogenicity in young infants of Haemophilus B tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis enhanced inactivated poliovirus vaccine. Pediatric Infect Dis J (1994) 13356-13362
26. Schmitt H.J., Knuf M., Ortiz E., Sanger R., Uwamwezi M.C., Kaufhold A., et al. Primary vaccination of infants with diphtheria-tetanus-acellular-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr 137 (2000) 304-312
27. Zepp F., Knuf M., Heininger U., Jahn K., Collard A., Habermehl P., et al. Safety reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine for primary immunisation of infants. Vaccine 22 (2004) 2226-2233
28. Ramkissoon A., Coovadia H.M., Jugnundan P., and Willems Clemens B.R. A new combined DTP-HBV-Hib vaccine strategy for incorporation of Hib vaccination into childhood immunization programs. S Afr Med J 91 10 (2001) 864-869
29. Yeh S.H., Ward J.I., Partridg S., Marcy S.M., Lee H., Jing J., et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr Infect Dis J 20 10 (2001) 973-980
30. Humphrey J.H., and Ichord R.N. Safety of vitamin A supplementation of post partum women and young children. Food Nutr Bull (2001) 311-319
31. Riedemann S., Reinhardt G., Jara J., Rios R., Wenzel M.S., Willems P., et al. Immunogenicity and reactogenicity of a combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months. Int J Infect Dis 6 (2002) 215-222
32. Dagan R., Igbaria K., Piglansky L., Melamed R., Willems P., Grossi A., et al. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated polio virus and Haemophilus Influenzae type b tetanus conjugate vaccine in infants compared with whole cell pentavalent vaccine. Pediatr Infect Dis J 16 (1997) 1113-1121
33. Hussey G., Malan H., Hughes J., Eley B., Piollet M., Charrondieres M., et al. Safety and immunogenicity of Tetrac Hib (a vaccine combining DTP vaccine and Haemophilus influenzae type b conjugate vaccine) administered to infants at 6,10 and 14 weeks. S Afr Med J 92 (2002) 53-57
34. Greenberg D.P., Vadheim C.M., Wong V.K., Marcy S.M., Partridge S., Greene T., et al. Comparative safety and immunogenicity of two recombinant vaccines given to infants at two, four and six months of age. Pediatr Infect Dis J 15 7 (1996) 590-596
35. Aristegui J., Dal Re R., Diez-Delgado J., Mares J., Cassanovas J.M., Garcia-Corbeira P., et al. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-PV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine administered as a single injection, with the DTPa-IPV/Hib and hepatitis vaccines administered in two simultaneous injections at 2, 4 and 6 months of age. Vaccine 21 (2003) 3593-3600
36. Carlsson R., Claesson B., Selstam U., Fagerlund E., Granstrom M., Blondeau C., et al. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis inactivated polio vaccine-Haemophilus Influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. Pediatr Infect Dis J (1998) 1026-1033